Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Consolidated Net Profit

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹772 Cr₹781 Cr₹1,212 Cr₹997 Cr₹773 Cr

What is the latest Consolidated Net Profit of GLAND PHARMA ?

The latest Consolidated Net Profit ratio of GLAND PHARMA is ₹772 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹772 Cr
Mar2024₹781 Cr
Mar2023₹1,212 Cr
Mar2022₹997 Cr
Mar2021₹773 Cr

How is Consolidated Net Profit of GLAND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹772 Cr
-1.10
Mar2024 ₹781 Cr
-35.54
Mar2023 ₹1,212 Cr
21.54
Mar2022 ₹997 Cr
29.00
Mar2021 ₹773 Cr -

Compare Consolidated Net Profit of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹39,242.8 Cr -3.3% 2.3% 18.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,711.0 Cr -0.8% 3.5% 14.7% Stock Analytics
DIVIS LABORATORIES ₹192,376.0 Cr -1% 7.3% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,655.0 Cr -0.9% 10.1% 44.6% Stock Analytics
CIPLA ₹113,979.0 Cr -2.1% -1.8% -6% Stock Analytics
DR REDDYS LABORATORIES ₹96,204.7 Cr -5.8% -13.2% -7.7% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-3.3%

2.3%

18.4%

SENSEX

-2.7%

-0.2%

-8%


You may also like the below Video Courses